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Summal~ 
To learn how lipooligosaccharide (LOS) phase variations  affect pathogenesis, we studied two 
male volunteers who were challenged intraurethrally with Neisseria gonorrhoeae that make a single 
LOS of 3,600 daltons and sequentially followed LOS expression by gonococci as urethritis developed. 
LOS variation occurred in vivo. Signs and symptoms of gonorrhea began with the appearance 
of variants making 4,700-dalton LOS that are immunochemically similar to glycosphingolipids 
of human hematopoietic cells (Man&ell, R. E., J. M. Griffiss, and B. A. Macher.  1989. J. Exp. 
Med. 168:107) and that have acceptors for sialic acid.  A variant that appeared  at the onset of 
leukorrhoea was shed by 34/36 men with naturally acquired gonorrhea at the time they sought 
medical attention; the other two shed the variant associated with dysuria. None shed the challenge 
variant. These data show that in vivo phase shifts to higher molecular mass LOS that mimic 
human cell membrane glycolipids are associated with the development of gonococcal leukorrhea. 
O 
uter membrane glycolipids of Gram-negative bacteria 
that  cause  disease  along  the  respiratory  or  genital 
mucosae are relatively small (<7,000-dalton)  lipooligosaccha- 
rides (LOS) 1 whose multiantennary oligosaccharide struc- 
tures mimic those of human cell membrane glycosphingolipids 
(GSL) (1-4).  During a study of the effect of piliation on in- 
fectivity,  human volunteers developed gonorrhea after  in- 
traurethral challenge with a piliated Ndsseria gonorrhoeae strfm 
(5) that made a single LOS of 3,600 daltons. We made serial 
analyses of the LOS made by the organisms infecting two 
of the volunteers to learn whether LOS phase variations oc- 
curred during infection. We then confirmed the results by 
studying men with naturally acquired gonorrhea. 
1  Abbreviations used in this tmper: GSL, glycosphingolipids;  LOS, lipooligo- 
saccharide. 
Materials  and  Methods 
Bacteria.  The heavily piliated,  nonopaque (5) challenge strain, 
MSllmk variant A, and its other variants were cultured as previ- 
ously described (6). 
We obtained gonococcal strains cultured from patients attending 
local sexually transmitted transmitted disease clinics as 24- or 48-h 
cultures on Martin-Lewis medium and confirmed their species (7). 
We used the growth on these primary cultures to make proteinase 
K  (PK)-treated whole cell lysates (8). 
LOS Analyses.  LOS in PK-treated lysates were characterized 
by SDS-PAGE and immunoblotting (6) with the use of mAbs 2-1- 
L8 (7),  3Fll,  6B4, and 1-1-M (9). 
Inflction of Volunteers.  Male volunteers were challenged with 
different inocula of variant A (5). Beginning 3 h after challenge, 
urine samples were collected twice daily until the infections were 
terminated by antibiotic treatment. Aliquots of centrifuged urine 
sediments were cultured and then stored frozen at  -90~  We 
recovered  bacteria retrospectively only from frozen sediments from 
two volunteers who were challenged with 10  s organisms;  bacteria 
in the other sediments did not survive  freezing. 
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by reacting them sequentially  with mAbs 3Fll or 1-1-M and 2-1- 
L8 (6). Progeny were studied by SDS-PAGE and immunoblot (6). 
Results and  Discussion 
Gonorrhea in men is characterized  by the onset of ure- 
thral dysuria and leukorrhoea after a variable incubation (10, 
11). Excretion of viable gonococci initially decreased in both 
volunteers and then steadily increased until dysuria and leu- 
korrhoea began between 48 and 96 h after challenge (Fig. 1). 
Gonococcal LOS participate in a complex mimicry of human 
cell surfaces, mAbs 3Fll and 6B4 recognize different epitopes 
within the Lacto-N-neotetraose moiety shared by the 4,800- 
dalton and larger gonococcal LOS (Fig.  2) and by human 
GSLs of the paragloboside series (1, 13-15).  Gonococci can 
leave the lactosamine (LacNAc) moiety unsubstituted or add 
GalNAc that occludes the 3Fll epitope and forms the 1-1-M 
epitope (Fig. 2 A) (14). LacNAc also has acceptors for sialic 
acid (15, 20). Sialylation variously occludes the 3Fll and 6B4 
epitopes; the 6B4 epitope is unaffected by GalNAc substitu- 
tion (14, 20). 
Three LOS variants were found in urine sediments (Fig. 
3). Variant A, the challenge variant, made single 3,600-dalton 
LOS, and bound only mAb 2-1-L8; after the initial decline 
in the numbers of organisms excreted (Fig. 1), it was recov- 
ered in increasing numbers from both volunteers until the 
onset of leukorrhoea (Table 1). Variant B appeared coincidental 
with the onset of inflammation and dysuria. In addition to 
the 3,600-dalton LOS, B made molecules of 4,300, 4,800, 
and 5,400 daltons (2, 7) (Fig. 2). Variant C  appeared after 
B and coincidental with the onset of urethritis and discharge 
(Table 1). It made the 4,300-, 4800-,  and 5,400-dalton LOS 
of variant B, and a 5,900-dalton LOS, but not the 3,600-dalton 
Table  1.  Gonococcal  LOS Variants Grown from Urine Sediments 
of Volunteers Infected with N. gonorrhoeae 
Study  Days post-  Retrospective 
no.  infection  Symptoms and signs  culture 
016  0  Dysuria  5/0/0* 
1  No dysuria  10/0/0 
2  Dysuria  172/3/0 
3  Dysuria  612/287/0 
4  Dysuria and discharge  88/678/15 
018  0  Dysuria  3/0/0 
1  No dysuria  3/0/0 
2  No dysuria  18/0/0 
3  No dysuria  0/0/0 
4  No dysuria  103/0/0 
5  Dysuria  385/14/0 
6  Dysuria and discharge  2/12/24 
Characterization of variants is described in the legend for Fig. 3. 
* Variant A colonies/variant B colonies/variant C colonies. 
LOS. A fourth variant, D, occurred only during in vitro pas- 
sage of variant C, and it made all five LOS (Fig.  2). 
Organisms from volunteer 016 at the onset of discharge 
show the LOS lineage A to B to C (Fig. 3). Variation from 
A to B represents the addition of LacNAc to the 3,600-dalton 
LOS (Fig.  2); the shift from B to C  represents  the loss of 
the 3,600-dalton precursor LOS and the acquisition of the 
5,900-dalton LOS. The emergence of variant C from within 
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Figure  1.  Quantitative cultures of 
sediments of  urine from volunteers  016 
and 018 challenged with 10  s N. gonor. 
rhoeae organisms. Aliquots  of  urine sedi- 
ment suspensions  from 50 ml urine were 
cultured and colonies  enumerated after 
24 and 48 h of incubation. Figure 2.  (A) Structure of the 5,400-dalton gonococcal LOS drawn from published structures of meningococcal (12) and gonococcal (1, 2,  13-17) 
LOS. Colors indicate the important antigenic and biosynthetic domains that comprise the epitopes that bind mAbs 2-1-L8 (13, 18, 19), 3Fll and 6B4 
(1, 2, 9,  13, 14, 20), and 1-1-M (9,  14). (B) SDS-PAGE separation of N. gonorrhoeae MSllmk variants A, B, C, and D  LOS, and the mAbs that they 
bind. PK lysates were separated on duplicate  SDS-PAGE gels. Lysates of PID2 and ML5 (variant D) were used as marker strains to estimate LOS molecular 
mass and to reference mAb binding to LOSs. Molecular mass was assigned  as previously described (7);  this method progressively overestimates  real 
molecular size as determined by mass  spectrometry (13). One gel was stained with silver (21) to reveal LOS. The second gel, used to assign mAb 
binding, was electroblotted to nitroceUulose paper and treated sequentially  with mAbs 3Fll, 6B4, 1-1-M, and 2-1-L8. The blot was treated with alkaline 
phosphatase-conjugated goat anti-mouse IgM (A-GAMM) after 3Fll and again after 1-1-M. Binding was detected as a red color produced by the alkaline 
phosphatase substrate,  naphthol-AS-MX-phosphate, and Fast Red TIL salt. Binding of mAb 6B4 was detected as a blue color by using horseradish 
peroxidase-conjugated goat anti-mouse IgM (P-GAMM), and the substrate hydrogen peroxide and 4-chloro-l-naphthol. mAb 2-I-L8 binding was de- 
tected using horseradish  peroxidase-conjugated goat anti-mouse IgG (P-GAMG) and the same peroxidase substrate. 
As expected from the known frequency of LOS phase vari- 
ation (10 -3) (6), we found eight variant C colonies among 
the 8,000 variant A colonies grown from the inoculum sus- 
pension.  This  means  that  10  s variant  C  organisms  were 
among the 10  s variant A organisms with which the volun- 
teers were challenged. 
If  variant C organisms in the challenge inoculum had had 
a survival advantage, we should have recovered some as the 
total numbers of shed organisms increased, but we did not. 
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Instead, we recovered  variant C organisms in proportiom much 
greater than in the inocula from both volunteers  after the 
onset of  urethral discharge, and they predominated in volun- 
teer 018 (Table 1). Mere persistence of variant C cells present 
in the challenge would have resulted in no more than one 
C organism on days 3 and 4 (1/1,000 organisms) for volun- 
teer 016 and no C organisms at any time for the other volun- 
teer, who shed <400 organisms. 
Variant B arose only in vivo; we did not find it among Figure 3.  Identification of LOS phase variants in the sediment of a urine 
passed by volunteer 016 at the onset of leukorrhoea  4 d after infection. 
Nitrocellulose colony lifts were treated sequentially with mAbs 3Fll and 
2-1-L8 as described for Fig. 2 B. The challenge variant A colonies (3Fll/2- 
1-L8 +) are blue; the variant B colonies (3Fll +/2-1-L8 +) are violet (red 
plus blue). Variant C organisms (3Fll +/2-1-L8-) appear as a red sector 
within a violet variant B colony. A silver-stained SDS-PAGE-separated  gel 
of PK lysates of each variant is provided in the inset. 
the challenge or in vitro passed organisms.  Its  abundance 
during development of symptomatic urethritis suggests that 
it is an intermediate step necessary for the in vivo transition 
from variant A to C as inflammation (dysuria) progresses to 
leukorrhoea (discharge). The presence of a variant C sector 
within a variant B colony (Fig. 3) is a clear demonstration 
that variant  C  cells did not have to be present  de novo. 
In contrast with the in vivo transition from variant A to 
B to C, a one-step change from variant A to C occurred in 
vitro.  This would suggest  that induction of variant B cells 
requires either an in vivo signal, or that they have an advan- 
tage that leads to their selection and persistence. Variant B 
expresses the Lacto-N-neotetraose acceptor for CMP-NANA 
(15). The acceptor site is occluded by the terminal GalNAc 
on 1-1-M-binding LOS (14). Sequential competition between 
sialyhtion and galactosylation  with the terminal GalNAc could 
explain the association  between LOS phase variance and symp- 
toms of infection. This model is consistent with our finding 
that gonococci within PMNs of naturally acquired urethral 
gonorrhea have sialylated surfaces that occlude binding by 
Figure 4.  Representative  SDS-PAGE  (top) and immunoblot  (bottom) anal- 
ysis of LOS made by N. gonorrhoeae strains recovered on primary culture 
from men seeking medical  attention for urethral gonorrhoea. ML5 (MS11mk 
variant D) and PID2 are included as molecular mass and mAb binding 
reference standards. Immunoblots were treated sequentially with mAbs 
3Fll, 1-1-M, and 2-1-L8, as described in Figs. 2 and 3. Outlines of the 
silver-stained LOS in the top were colored to indicate mAb binding. 
mAbs that recognize the Lacto-N-neotetraose  LOS substit- 
uent (20). It implies that the nonsialylated A variants estab- 
lished the infection  and the potentially sialylated B and C 
variants caused disease. 
To confirm this model we assessed whether gonococci re- 
covered from men with naturally acquired gonorrhoea ex- 
pressed LOS that bound mAbs 2-1-L8 and 3Fll (Fig. 4). Strains 
from 36 men bound mAb 3Fll to one or more LOS of>4,700 
daltons,  and of these only two bound mAb 2-1-L8. Thus, 
34 (94.4%) were shedding organisms with characteristics of 
variant C, and two (5.6%) were shedding organisms with 
characteristics of  variant B, when they sought medical atten- 
tion. None were shedding variant A. Half of the men's strains 
also bound mAb 1-1-M. 
These observations support the conclusion that persistent 
colonization and development of symptomatic gonorrhea re- 
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higher molecular mass LOS, at least one of which shares an 
oligosaccharide with paragloboside, a GSL of human cells. 
Expression of this shared oligosaccharide and its potential 
subsequent sialylation is likely to be a necessary component 
of virulence for the male urethra. 
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